BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1648861)

  • 1. Ganglioside GD3 shedding by human gliomas.
    Nakamura O; Iwamori M; Matsutani M; Takakura K
    Acta Neurochir (Wien); 1991; 109(1-2):34-6. PubMed ID: 1648861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LGI1 tumor tissue expression and serum autoantibodies in patients with primary malignant glioma.
    Dazzo E; Pasini E; Furlan S; de Biase D; Martinoni M; Michelucci R; Nobile C;
    Clin Neurol Neurosurg; 2018 Jul; 170():27-33. PubMed ID: 29723732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals.
    Nijaguna MB; Patil V; Hegde AS; Chandramouli BA; Arivazhagan A; Santosh V; Somasundaram K
    PLoS One; 2015; 10(9):e0137524. PubMed ID: 26390214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside content and composition in human gliomas.
    Gaini SM; Riboni L; Cerri C; Grimoldi N; Sganzerla EP; Berra B
    Acta Neurochir Suppl (Wien); 1988; 43():126-9. PubMed ID: 2850730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganglioside profiles in human gliomas: quantification by microbore high performance liquid chromatography and correlation to histomorphology and grading.
    Wagener R; Röhn G; Schillinger G; Schröder R; Kobbe B; Ernestus RI
    Acta Neurochir (Wien); 1999; 141(12):1339-45. PubMed ID: 10672306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
    Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
    Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers of brain tumours.
    Lyubimova NV; Toms MG; Fu RG; Bondarenko YV
    Klin Lab Diagn; 2013 Oct; (10):71-2, 40-2. PubMed ID: 24640102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of ganglioside GD3 in neoplastic astrocytes. An immunocytochemical study in humans.
    Kawai K; Takahashi H; Watarai S; Ishizu H; Fukai K; Tanabe Y; Nose S; Kuroda S
    Virchows Arch; 1999 Mar; 434(3):201-5. PubMed ID: 10190298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients.
    Hallal S; Ebrahim Khani S; Wei H; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum gangliosides in patients with brain tumors.
    Radić B; Vukelić Z; Bognar SK
    Coll Antropol; 2008 Jan; 32 Suppl 1():171-5. PubMed ID: 18405078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum gangliosides in cerebral astrocytoma.
    Lo HS; Hogan EL; Koontz DA; Traylor TD
    Ann Neurol; 1980 Nov; 8(5):534-8. PubMed ID: 7436395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular and perivascular GD3 expression in human glioma.
    Koochekpour S; Pilkington GJ
    Cancer Lett; 1996 Jun; 104(1):97-102. PubMed ID: 8640753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant ganglioside composition in glioblastoma multiforme and peritumoral tissue: A mass spectrometry characterization.
    Fabris D; Rožman M; Sajko T; Vukelić Ž
    Biochimie; 2017 Jun; 137():56-68. PubMed ID: 28286312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A panel of four cytokines predicts the prognosis of patients with malignant gliomas.
    Lin Y; Zhang G; Zhang J; Gao G; Li M; Chen Y; Wang J; Li G; Song SW; Qiu X; Wang Y; Jiang T
    J Neurooncol; 2013 Sep; 114(2):199-208. PubMed ID: 23748572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of foetal ganglioside antigens 3'-isoLM1 and 3'6'-isoLD1 in both glioma tissue and surrounding areas from human brain.
    von Holst H; Nygren C; Boström K; Collins VP; Fredman P
    Acta Neurochir (Wien); 1997; 139(2):141-5. PubMed ID: 9088372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum protein fingerprinting coupled with artificial neural network distinguishes glioma from healthy population or brain benign tumor.
    Liu J; Zheng S; Yu JK; Zhang JM; Chen Z
    J Zhejiang Univ Sci B; 2005 Jan; 6(1):4-10. PubMed ID: 15593384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of medulloblastoma and astrocytoma-associated ganglioside GD3 in cerebrospinal fluid.
    Ladisch S; Chang F; Li R; Cogen P; Johnson D
    Cancer Lett; 1997 Nov; 120(1):71-8. PubMed ID: 9570388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganglioside composition and its relation to clinical data in brain tumors.
    Shinoura N; Dohi T; Kondo T; Yoshioka M; Takakura K; Oshima M
    Neurosurgery; 1992 Sep; 31(3):541-9. PubMed ID: 1407435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glioma-associated gangliosides 3'-isoLM1, GD3 and GM2 show selective area expression in human glioblastoma xenografts in nude rat brains.
    Hedberg KM; Mahesparan R; Read TA; Tysnes BB; Thorsen F; Visted T; Bjerkvig R; Fredman P
    Neuropathol Appl Neurobiol; 2001 Dec; 27(6):451-64. PubMed ID: 11903928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of gangliosides GD3 and 3'-isoLM1 in autopsy brains from patients with malignant tumors.
    Fredman P; von Holst H; Collins VP; Dellheden B; Svennerholm L
    J Neurochem; 1993 Jan; 60(1):99-105. PubMed ID: 8417168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.